Persistent chlamydia infections result in Bacterial vaginosis: Study
Greater chlamydia persistence is linked to bacterial vaginosis (BV), says an article published in the Journal of Infectious Diseases. Between diagnosis and therapy, up to 26% of urogenital Chlamydia trachomatis infections resolve on their own. It is uncertain what mechanisms control natural resolution. In order to determine if bacterial vaginosis was linked to increased chlamydia persistence vs spontaneous clearance in a large, longitudinal investigation, Brown and colleagues conducted this study.
The Longitudinal Study of Vaginal Flora tracked women of reproductive age four times a year from 1999 to 2003. After ligase chain reaction testing became available mid-study, baseline chlamydia screening and treatment were started, and unscreened endocervical samples were analyzed after study completion. Between successive visits without the use of chlamydia-active medicines, chlamydia clearance and persistence were determined (N = 320 persistence/N = 310 clearance). Alternating and conditional logistic regression was used to model the relationships between the Nugent score (0-3, no BV; 4-10, intermediate/BV), Amsel-BV, and the persistence vs clearance of chlamydia.
The key findings of this study were;
1. 48% of chlamydia cases (310/630) spontaneously resolved by the subsequent visit.
2. Higher chances of chlamydia persistence were found to be related with Nugent-Intermediate/BV (aOR = 1.89, 95% CI:1.30-2.74), and Amsel-BV (aOR 1.39, 95% CI:0.99-1.96).
3. A within-participant study of 67 subjects with both clearance and persistence intervals revealed a greater correlation with Nugent-Intermediate/BV and chlamydia persistence (aOR = 4.77, 95% CI: 1.39-16.35).
4. Results were unaffected by BV symptoms.
Unfortunately, chlamydia infection rates continue to be unacceptable high despite government recommendations to test all sexually active women under the age of 25 at least once a year. In order to prevent chlamydia in women, new measures are required. Long-term development of novel biotherapeutics, such as probiotics, to prevent chlamydia, facilitate chlamydial clearance, and enhance reproductive health could be influenced by an understanding of the complex factors, including host, pathogen, and microbiome factors, that result in spontaneous clearance of chlamydia.
Reference:
Brown, S. E., Tuddenham, S., Shardell, M. D., Klebanoff, M. A., Ghanem, K. G., & Brotman, R. M. (2023). Bacterial vaginosis and spontaneous clearance of Chlamydia trachomatis in the Longitudinal Study of Vaginal Flora. In The Journal of Infectious Diseases. Oxford University Press (OUP). https://doi.org/10.1093/infdis/jiad142
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.